Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.

Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 0243532 Publication Model: Print Cited Medium: Print ISSN: 0041-1345 (Print) Linking ISSN: 00411345 NLM ISO Abbreviation: Transplant Proc Subsets: MEDLINE

Publication: New York, N.Y. : Elsevier Science Inc.
Original Publication: New York Stratton.

Graft Rejection/*drug therapy ; Hepatitis C/*surgery ; Immunosuppressive Agents/*therapeutic use ; Liver Cirrhosis/*surgery ; Liver Transplantation/*immunology ; Mycophenolic Acid/*analogs & derivatives; Antibodies, Monoclonal/therapeutic use ; Cyclosporine/therapeutic use ; Hepatitis C/complications ; Hepatitis C/physiopathology ; Humans ; Liver Cirrhosis/etiology ; Liver Transplantation/mortality ; Methylprednisolone/therapeutic use ; Muromonab-CD3/therapeutic use ; Mycophenolic Acid/therapeutic use ; Receptors, Interleukin-2/immunology ; Recurrence ; Reoperation ; Retrospective Studies ; Survival Rate ; Tacrolimus/therapeutic use ; Time Factors

0 (Antibodies, Monoclonal)
0 (Immunosuppressive Agents)
0 (Muromonab-CD3)
0 (Receptors, Interleukin-2)
83HN0GTJ6D (Cyclosporine)
GO90DFK14U (inolimomab)
HU9DX48N0T (Mycophenolic Acid)
WM0HAQ4WNM (Tacrolimus)
X4W7ZR7023 (Methylprednisolone)

Date Created: 19980624 Date Completed: 19980708 Latest Revision: 20190713

20240628

10.1016/s0041-1345(98)00319-4

9636596